aid: acurastem
name: AcuraStem
description: 'AcuraStem, Inc. is a privately held, patient-based biotechnology company
  headquartered in Monrovia, California, developing therapeutics for neurodegenerative
  diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal
  dementia (FTD). The company''s proprietary iNeuroRx drug-discovery platform builds
  disease models from induced pluripotent stem cells (iPSC) taken from individual patients,
  in place of animal models, and pairs them with machine-learning analysis to identify
  and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE),
  is advancing toward first-in-human testing with California Institute for Regenerative
  Medicine (CIRM) grant support. AcuraStem is a therapeutics developer rather than a
  software vendor: it publishes no public API, developer portal, SDK, or machine-readable
  contract of any kind. This profile records that absence with the probe evidence behind
  it.'
url: https://raw.githubusercontent.com/api-evangelist/acurastem/refs/heads/main/apis.yml
image: https://acurastem.com/application/files/7516/7235/4056/acs_logo_notag.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Therapeutics
- Life Sciences
- Drug Discovery
- Neuroscience
- Neurodegenerative Disease
- ALS
- Stem Cells
- Machine Learning
- Private Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/acurastem-domain-security.yml
- type: LLMsTxt
  url: llms/acurastem-llms.txt
- type: Website
  url: https://acurastem.com/
- type: About
  url: https://acurastem.com/about-us
- type: Blog
  url: https://acurastem.com/blog
- type: Newsroom
  url: https://acurastem.com/media
- type: Careers
  url: https://acurastem.com/careers
- type: PrivacyPolicy
  url: https://acurastem.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/12903559/
- type: X
  url: https://x.com/acurastem
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: AcuraStem is a preclinical ALS/FTD therapeutics developer whose entire public
    web presence is a six-page Concrete CMS 9.5.2 marketing site (about, science, therapeutics,
    media, careers) with no developer, API, or data-access section, no API subdomain
    resolving in DNS, and an empty GitHub organization with zero public repositories.
  evidence:
  - url: https://acurastem.com/
    status: 200
  - url: https://acurastem.com/openapi.json
    status: 404
  - url: https://acurastem.com/.well-known/api-catalog
    status: 404
  - url: https://acurastem.com/llms.txt
    status: 404
  - url: https://acurastem.com/sitemap.xml
    status: 200
  - url: https://api.github.com/orgs/acurastem
    status: 200
  checked: '2026-09-06'